Literature DB >> 26055579

Understanding thrombocytopenia: physiological role of microRNA in survival of neonatal megakaryocytes.

Ravinder Kandi1, Usha Gutti, Rambabu Undi, Itishri Sahu, Ravi Kumar Gutti.   

Abstract

Neonates are predisposed to developing thrombocytopenia and neonates are affected by megakaryocytic disorders such as thrombocytopenia with absent radius syndrome and transient myeloproliferative disorder. Small double stranded non-coding microRNAs (miRNAs) have been shown to crucially involve in the regulation of stem-cell differentiation in normal as well as malignant haematopoiesis. The regulatory mechanism in developmental megakaryocytopoiesis and role of miRNAs in biological differences between adult and neonatal megakaryopoiesis is unknown. Here in we compared miR-99a levels in megakaryocytes (MKs) derived from cord blood (CB) and peripheral blood using qRT-PCR. CTDSPL is predicted as potential target of miR-99a and was confirmed by western blot. CTDSPL is shown to involve in regulation of cell growth and differentiation and exhibits tumor suppressor activity. We believe that miR-99a regulates CTDSPL, which induces the G1/S transition by increasing Cyclin expression and play a significant role in proliferation of CB-MKs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26055579     DOI: 10.1007/s11239-015-1238-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  18 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  MicroRNA fingerprints during human megakaryocytopoiesis.

Authors:  Ramiro Garzon; Flavia Pichiorri; Tiziana Palumbo; Rodolfo Iuliano; Amelia Cimmino; Rami Aqeilan; Stefano Volinia; Darshna Bhatt; Hansjuerg Alder; Guido Marcucci; George A Calin; Chang-Gong Liu; Clara D Bloomfield; Michael Andreeff; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

3.  MiR-125b and miR-99a encoded on chromosome 21 co-regulate vincristine resistance in childhood acute megakaryoblastic leukemia.

Authors:  Ravinder Kandi; Usha Gutti; Raja Gopal Venakata Saladi; Ravi Kumar Gutti
Journal:  Hematol Oncol Stem Cell Ther       Date:  2014-12-27

4.  Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin.

Authors:  M C Sola; Y Du; A D Hutson; R D Christensen
Journal:  Br J Haematol       Date:  2000-08       Impact factor: 6.998

5.  Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?

Authors:  H Sallmon; R K Gutti; F Ferrer-Marin; Z-J Liu; M C Sola-Visner
Journal:  J Perinatol       Date:  2010-04-22       Impact factor: 2.521

6.  RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies.

Authors:  Vladimir I Kashuba; Jingfeng Li; Fuli Wang; Vera N Senchenko; Alexey Protopopov; Alena Malyukova; Alexey S Kutsenko; Elena Kadyrova; Veronika I Zabarovska; Olga V Muravenko; Alexander V Zelenin; Lev L Kisselev; Igor Kuzmin; John D Minna; Gösta Winberg; Ingemar Ernberg; Eleonora Braga; Michael I Lerman; George Klein; Eugene R Zabarovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

7.  MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.

Authors:  F Akbari Moqadam; E A M Lange-Turenhout; I M Ariës; R Pieters; M L den Boer
Journal:  Leuk Res       Date:  2013-07-31       Impact factor: 3.156

8.  miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesis.

Authors:  Elik Chapnik; Natalia Rivkin; Alexander Mildner; Gilad Beck; Ronit Pasvolsky; Eyal Metzl-Raz; Yehudit Birger; Gail Amir; Itay Tirosh; Ziv Porat; Liron L Israel; Emmanuel Lellouche; Shulamit Michaeli; Jean-Paul M Lellouche; Shai Izraeli; Steffen Jung; Eran Hornstein
Journal:  Elife       Date:  2014-05-23       Impact factor: 8.140

9.  High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.

Authors:  Vladimir I Kashuba; Tatiana V Pavlova; Elvira V Grigorieva; Alexey Kutsenko; Surya Pavan Yenamandra; Jingfeng Li; Fuli Wang; Alexei I Protopopov; Veronika I Zabarovska; Vera Senchenko; Klas Haraldson; Tatiana Eshchenko; Julia Kobliakova; Olga Vorontsova; Igor Kuzmin; Eleonora Braga; Vladimir M Blinov; Lev L Kisselev; Yi-Xin Zeng; Ingemar Ernberg; Michael I Lerman; George Klein; Eugene R Zabarovsky
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

10.  MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia.

Authors:  Lidan Zhang; Xiaojuan Li; Zhiyong Ke; Libin Huang; Yanni Liang; Jun Wu; Xiaoli Zhang; Yueqin Chen; Hua Zhang; Xuequn Luo
Journal:  Cancer Cell Int       Date:  2013-11-05       Impact factor: 5.722

View more
  3 in total

Review 1.  Megakaryocyte ontogeny: Clinical and molecular significance.

Authors:  Kamaleldin E Elagib; Ashton T Brock; Adam N Goldfarb
Journal:  Exp Hematol       Date:  2018-03-02       Impact factor: 3.084

Review 2.  Changes in megakaryopoiesis over ontogeny and their implications in health and disease.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Platelets       Date:  2020-03-21       Impact factor: 3.862

3.  Fetal vs adult megakaryopoiesis.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.